no statement of use filed
on 21 Jan 2019
Last Applicant/ Owned by
Dublin City University
Dublin
IE
9
Serial Number
87121385 filed on 29th Jul 2016
Registration Number
N/A
Correspondent Address
RODNEY L. SKOGLUND
RENNER KENNER GREIVE BOBAK TAYLOR & WEBE
FIRST NATIONAL TOWER, SUITE 400
106 SOUTH MAIN STREET
AKRON, OH, , 44308
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
(based on intent to use and Section 44e) pharmaceutical and veterinary preparations and substances allowing for controlled absorption and/or controlled release of an active ingredient following administration to human and non-human animals for the treatment of cardiovascular disorders, central nervous system disorders, acute and chronic pain, epilepsy, insomnia, learning disorders, infectious diseRead More
(based on intent to use and Section 44e) pharmaceutical and veterinary preparations and substances allowing for controlled absorption and/or controlled release of an active ingredient following administration to human and non-human animals for the treatment of cardiovascular disorders, central nervous system disorders, acute and chronic pain, epilepsy, insomnia, learning disorders, infectious diseases, gastrointestinal diseases, diabetes, impotence, obesity, skin disorders, host-graft rejections, arthritis and autoimmune disorders; (based on intent to use) Pharmaceutical and veterinary preparations and substances for the treatment of cardiovascular disorders, central nervous system disorders, acute and chronic pain, epilepsy, insomnia, learning disorders, infectious diseases, gastrointestinal diseases, diabetes, impotence, obesity, skin disorders, host-graft rejections, arthritis and autoimmune disorders
(based on intent to use and Section 44e) Scientific and biological research relating to the research and development of pharmaceutical and veterinary preparations and substances allowing for controlled absorption and/or controlled release of an active ingredient following administration to human and non-human animals and based on liquid emulsion drug delivery systems; medical research relating to the diagnosis and treatment of disease involving the use of pharmaceutical and veterinary preparations and substances allowing for controlled absorption and/or controlled release of an active ingredient following administration to human and non-human animals and based on liquid emulsion drug delivery systems; (based on intent to use) Scientific and biological research relating to the research and development of pharmaceutical and veterinary preparations and substances; medical research relating to the diagnosis and treatment of disease; medical research on the efficacy of pharmaceutical and veterinary preparations and substances; medical and scientific research, namely, conducting clinical trials involving pharmaceutical and veterinary preparations and substances
No 87121385
No Service Mark
No COU.T.US0054
No
No
No
No
No
No
No
No
| Status Date | Action Taken |
|---|---|
| 22nd Jan 2019 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| 21st Jan 2019 | ABANDONMENT - NO USE STATEMENT FILED |
| 05th May 2018 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 03rd May 2018 | EXTENSION 1 GRANTED |
| 03rd May 2018 | EXTENSION 1 FILED |
| 03rd May 2018 | TEAS EXTENSION RECEIVED |
| 19th Dec 2017 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 24th Oct 2017 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 24th Oct 2017 | PUBLISHED FOR OPPOSITION |
| 04th Oct 2017 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
